Reply
Ophthalmology
.
2018 Aug;125(8):e57.
doi: 10.1016/j.ophtha.2018.03.023.
Authors
Deborah M Costakos
1
,
Ryan Vogel
2
,
Joseph Carroll
2
Affiliations
1
Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: dcostakos@mcw.edu.
2
Medical College of Wisconsin, Milwaukee, Wisconsin.
PMID:
30032804
DOI:
10.1016/j.ophtha.2018.03.023
No abstract available
Publication types
Letter
Comment
MeSH terms
Bevacizumab
Fovea Centralis
Humans
Infant
Infant, Newborn
Infant, Newborn, Diseases*
Light Coagulation
Retinopathy of Prematurity*
Substances
Bevacizumab